GREAT
CONNECT
Our corporate culture is
righteousness and integrity.
Articles of Incorporation
Manage the company
by complying with
the basic principle of articles of incorporation.
Chapter I General Provisions
Article 1 (Corporate Name)
Article 2 (Purpose)
Article 3 (Location of the Head Office and Establishment of Branches)
Article 4 (Method of Public Notice)
Chapter II Shares
Article 5 (Total Number of Shares to be Issued)
Article 6 (Par Value per Share)
Article 7 (Total Number of Shares to be Issued at the Time of Incorporation)
Article 8 (Classes of Shares)
Article 8-2 (Number and Content of Class Shares ①)
Article 8-3 (Number and Content of Class Shares ②)
Article 8-4 (Number and Content of Class Shares ③)
Article 8-5 (Number and Content of Class Shares ④)
Article 9 (Electronic Registration of the Rights to be Indicated on Shares or on Preemptive Right Certificates)
Article 10 (Preemptive Rights)
Article 10-2 (Stock Options)
Article 10-3 (Record Date for Calculation of Dividends for New Shares)
Article 11 (Transfer Agent)
Article 12
Article 13 (Closure of Register of Shareholders and Record Date)
Chapter III Bonds
Article 14 (Issuance of Convertible Bonds)
Article 15 (Issuance of Bonds with Warrants)
Article 15-2 (Electronic Registration of the Rights to be indicated on Bonds or Preemptive Right Certificates)
Article 16 (Applicable Provisions Concerning Issuance of Bonds)
Chapter IV General Meeting of Shareholders
Article 17 (Convocation of General Meetings and Place for Convocation)
Article 18 (Persons Authorized to Convene)
Article 19 (Notice and Public Notice of Convening of General Meeting)
Article 20 (Chairperson)
Article 21 (Chairperson's Authority to Maintain Order)
Article 22 (Voting Right and Voting by Proxy)
Article 23 (Limitation on Voting Rights of Cross-Held Shares)
Article 24 (Exercise of Voting Rights in Disunity)
Article 25 (Methods of Adopting Resolutions)
Article 26 (Minutes of General Meeting)
Chapter V Directors, Board of Directors and Auditors
Article 27 (Number of Directors and Auditors)
Article 28 (Appointment and Term of Office of Directors and Auditors)
Article 29 (Vacancies)
Article 30 (Appointment of Representative Director and Others)
Article 31 (Duties of Representative Director and Others)
Article 31-2 (Directors' Duty of Reporting)
Article 32 (Duties of Auditors)
Article 33 (Audit Records)
Article 34 (Convocation of Board of Directors' Meetings and Chairperson)
Article 35 (Methods of Resolution by Board of Directors)
Article 35-2 (Liability Release to Company)
Article 36 (Minutes of Board of Directors' Meeting)
Article 36-2 (Committees)
Article 37 (Remuneration for Directors and Auditors)
Article 38 (Advisors)
Chapter VI Accounting
Article 39 (Business Year)
Article 40 (Preparation and Maintenance of Financial Statements)
Article 41 (Disposition of Profits)
Article 41-2 (Retirement of Shares)
Article 42 (Dividends)
Article 43 (Statute of Limitations for a Claim for Payment of Dividends)
Addenda
Article 1 (Bylaws and Detailed Rules)
Article 2 (Matters Not Specified in These Articles of Incorporation)
Article 3 (Enforcement Date)
Key Agenda Items and Resolutions
| Date | Agenda | Approval | Voting Rights | Attended | Approval Rate |
|---|---|---|---|---|---|
| The 60th AGM (March 26, 2026) |
No. 1 Approval of The 60th Financial Statements | Approved | 44,973,535 | 32,555,732 | 99.6% |
| No. 2 Approval of amendments to the Articles of Incorporation | Approved | 81.2% | |||
| No. 3 Election of Independent Director (Chun-Woo Lee) | Approved | 99.3% | |||
| No. 4 Approval of Director Remuneration Limit | Approved | 35,468,831 | 23,051,028 | 79.5% | |
| No. 5 Approval of Auditor Remuneration Limit | Approved | 44,973,535 | 32,555,732 | 99.3% | |
| No. 6 Approval of the Plan for Holding and Disposing of Treasury Shares | Approved | 90.7% | |||
| The 59th AGM (March 26, 2025) |
No. 1 Approval of The 59th Financial Statements | Approved | 44,934,190 | 32,178,026 | 99.0% |
| No. 2-1 Election of Director (Il-Sub Huh) | Approved | 99.0% | |||
| No. 2-2 Election of Director (Yong-Jun Huh) | Approved | 96.4% | |||
| No. 2-3 Election of Director (Yong-Tae Park) | Approved | 98.9% | |||
| No. 2-4 Election of Independent Director (Jun-Ho Kang) | Approved | 99.3% | |||
| No. 3 Approval of Director Remuneration Limit | Approved | 22,737,795 | 90.0% | ||
| No. 4 Approval of Auditor Remuneration Limit | Approved | 32,178,026 | 99.2% | ||
| The 58th AGM (March 28, 2024) |
No. 1 Approval of The 58th Financial Statements | Approved | 44,934,190 | 31,123,844 | 99.1% |
| No. 2 Approval of amendments to the Articles of Incorporation | Approved | 99.5% | |||
| No. 3 Election of Independent Director (Suk-Wha Kim) | Approved | 98.9% | |||
| No. 4 Election of Auditor (Sang-Syeb Kim) | Approved | 98.0% | |||
| No. 5 Approval of Director Remuneration Limit | Approved | 44,934,190 | 8,496,695 | 90.3% | |
| No. 6 Approval of Auditor Remuneration Limit | Approved | 44,934,190 | 31,123,844 | 99.5% |
Dividend Information
| Classification | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total Dividends (KRW 1 Billion) |
18.2 | 13.6 | 13.6 | 22.7 | 13.6 |
| Dividends per Share (KRW) |
400 | 300 | 300 | 500 | 300 |
| Dividend Payout Ratio | 50.9% | 84.5% | 60.3% | 14.0% | - |
| Dividend Yield | 1.5% | 1.7% | 1.9% | 2.9% | 2.0% |
[Dividend Policy]
GC implements annual dividends to share its business performance with shareholders. With the primary goal of enhancing shareholder value and expanding shareholder returns, the Company plans to execute dividends within the scope of net income on a separate financial statement basis, considering factors such as the current year's earnings, financial soundness, and the overall business environment.
To ensure the continuity and predictability of dividends and to strengthen transparency in our shareholder return policy, we announced a mid-to-long-term shareholder return policy in February 2026. The key criteria for the three-year (2026-2028) policy are as follows:
[Mid-to-Long-Term Dividend Policy]
Target: A dividend payout ratio of 50% or more based on the 3-year average net income (Separate Financial Statements).
(Note: One-off non-recurring gains/losses and valuation gains/losses are excluded from the calculation.)
The annual dividend scale is determined by the Board of Directors and communicated to shareholders through public disclosures (Decision on Cash/In-kind Dividend). Dividend payments are distributed within one month following approval at the Annual General Meeting of Shareholders.
[Dividend Predictability]
(1) Status of Implementation of Amendments to the Dividend Procedure in the Articles of Incorporation
| Category | Final Dividend | Interim / Quarterly Dividend |
|---|---|---|
| Decision-making body for setting the dividend record date under the articles of incorporation | General Meeting of Shareholders | Board of Directors |
| Whether the dividend record date may be set after the dividend amount is determined | Yes | Yes |
| Future plans regarding implementation of amendments to the dividend procedure | In progress | Under review, taking into account shareholder value and the Company's business performance |
(2) Status of Dividend Amount Determination and Dividend Record Date Designation
| Category | Fiscal Year | Dividend Paid | Dividend Amount Determination Date |
Dividend Record Date | Dividend Predictability Provision Status | Remarks |
|---|---|---|---|---|---|---|
| Final dividend | December 2025 | O | February 11, 2026 | March 31, 2026 | O | - |
| Final dividend | December 2024 | O | February 11, 2025 | December 31, 2024 | X | - |
| Final dividend | December 2023 | O | February 14, 2024 | December 31, 2023 | X | - |
Board of Directors (BOD)
| Title | Name | Career | Start Date | End Date |
|---|---|---|---|---|
| CEO | Il-Sub Huh | BA in Business Administration, Seoul National University MBA, Indiana University Ph.D in Business Administration, University of Houston Chairman, GC Corp. |
March 29, 2025 | March 29, 2027 |
| CEO | Yong-Jun Huh | BS in Science, Yonsei University MBA, University of Wisconsin President, GC Corp. |
March 29, 2025 | March 29, 2027 |
| Director | Yong-Tae Park | BS in Metal Engineering, Hanyang University Vice Chairman, GC Corp. |
March 29, 2025 | March 29, 2027 |
| Independent Director | Suk-Wha Kim | M.D, Seoul National University College of Medicine (Former) Professor, Seoul National University College of Medicine (Present) Professor, CHA Medical Center |
March 29, 2024 | March 29, 2026 |
| Independent Director | Joon-Ho Kang | B. A., Seoul National University, Kinesiology M.B.A., The University of Pennsylvania Ph. D., The University of Michigan, Sport Management Assistant professor in sport management, Department of Kinesiology, University of Connecticut (1998. 8 – 2001. 1) Dean, Office of Planning and Coordination, Seoul National University (2019.2 – 2021.2) Member of the Olympism 365 Commission Director, The Division of Global Sport Talent Development, Seoul National University (2013. 5 – present) Director, The Center for Sport Industry, Seoul National University (2004. 1 – present) Professor in Sport Management, Global Sport Management Program, Department of Physical Education, Seoul National University (2008. 10 – present) |
March 26, 2025 | March 26, 2027 |
Board Skills Matrix (2025.12.12)
| Expertise Categories | Executive Director | Independent Director | |||
|---|---|---|---|---|---|
| Il-Sub Huh | Yong-Tae Park | Yong-Jun Huh | Suk-Wha Kim | Joon-Ho Kang | |
| Leadership | ● | ● | ● | ● | ● |
| Board Experience | ● | ● | ● | ● | ● |
| Finance & Accounting | ● | ● | |||
| Risk Management | ● | ● | ● | ● | |
| Industry Experience (Pharmaceuticals, Bio, Medical, Healthcare) | ● | ● | ● | ● | |
| Global Business | ● | ● | ● | ● | ● |
| Global Business / M&A, Investment, Capital Markets | ● | ● | ● | ||
| Legal, Administrative, Public Policy | |||||
| HR, Compensation | ● | ● | |||
| Diversity Categories | Il-Sub Huh | Yong-Tae Park | Yong-Jun Huh | Suk-Wha Kim | Joon-Ho Kang |
|---|---|---|---|---|---|
| Tenure | 34 yrs | 16 yrs | 8 yrs | 5 yrs | 1 yr |
| Age | 71 | 75 | 51 | 70 | 58 |
| Gender | Male | Male | Male | Male | Male |
BOD Activities
| No. | Date | Agenda | Results | Attendance of Independent Directors |
|---|---|---|---|---|
| 1 | 11 Feb. 2025 |
1. Approval of Financial Statements and Annual Report 2. Convening of the Annual General Meeting of Shareholders 3 Determination of the Agenda Items for the AGM 4. Appointment of the Chairperson of the AGM 5. Amendment to the Internal Accounting Management Regulations 6. Approval of Treasury Stock Report Matters for Reporting Report on the Operation Status of the Internal Accounting Management System Report on the Evaluation of the Internal Accounting Management System Report on New Investments |
Approved Approved Approved Approved Approved Approved - - - |
2/2 |
| 2 | 27 Feb. 2025 | 1. Determination of the Agenda Items for the AGM | Approved | 2/2 |
| 3 | 26 Mar. 2025 |
1. Appointment of the Chief Executive Officer 2. Appointment of the Chairman of the Board of Directors 3. Appointment of the Compliance Officer 4. Appointment of the Compliance Program Officer |
Approved Approved Approved Approved |
2/2 |
| 4 | 20 May 2025 |
1. Approval of Corporate Bond Issuance
Matters for Reporting 1. Business Status of Affiliated Companies 2. Status of Overseas Business 3. Key Business Updates |
Approved
- - - |
2/2 |
| 5 | 26 Sep. 2025 |
Matters for Reporting 1. Management Performance for the 3rd Quarter of 2025 2. Report on the Results of Corporate Bond Issuance 3. Key Business and Management Status of Subsidiaries |
- - - |
2/2 |
| 6 | 12 Dec. 2025 |
1. Disposal of Treasury Shares
※ Matters for Reporting 1. Compliance Officer Activities and Operation of ISO 37301 2. Report on the Proposed Amendment to the Record Date for Dividend Distribution 3. ESG Implementation Status 4. Management Performance for 2025 5. Management Objectives and Plans for 2026 6. Proposed 2026 Board Meeting Schedule 7. Business Status of Affiliated Family Companies |
Approved
- - - - - - - |
2/2 |
Rejection of e-mail collection
GC는 이메일 수집을 거부합니다
본 웹사이트에 게시된 이메일 주소가 전자우편 수집 프로그램이나 그 밖의 기술적 장치를 이용하여 무단으로 이메일 주소를 수집하는 행위를 거부하며, 이를 위반시 정보통신망 이용촉진 및 정보보호 등에 관한 법률에 의해 형사처벌됨을 유념하시기 바랍니다.
게시일: 2003년 9월 1일
GC FAMILY SITE
Pharmaceutical
PharmaceuticalHealthcare
HealthcareDiagnosis
DiagnosisOverseas
OverseasGC Biopharma do Brasil
Foundation
FoundationMoreover
MoreoverGC Invacfarm